214 related articles for article (PubMed ID: 29530714)
21. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
22. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
[TBL] [Abstract][Full Text] [Related]
23. Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).
Woyna-Orlewicz K; Brniak W; Tatara W; Strzebońska M; Haznar-Garbacz D; Szafraniec-Szczęsny J; Antosik-Rogóż A; Wojteczko K; Strózik M; Kurek M; Jachowicz R; Mendyk A
Pharm Res; 2023 Dec; 40(12):2947-2962. PubMed ID: 37726407
[TBL] [Abstract][Full Text] [Related]
24. Characterization of mannitol granules and powder: A comparative study using two flowability testers.
Takeuchi Y; Tomita T; Kuroda J; Kageyu A; Yonekura C; Hiramura Y; Tahara K; Takeuchi H
Int J Pharm; 2018 Aug; 547(1-2):106-113. PubMed ID: 29803796
[TBL] [Abstract][Full Text] [Related]
25. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.
Gulsun T; Akdag Y; Izat N; Cetin M; Oner L; Sahin S
Pharm Dev Technol; 2020 Oct; 25(8):999-1009. PubMed ID: 32431206
[TBL] [Abstract][Full Text] [Related]
27. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
28. Application of polyvinyl acetate in an innovative formulation strategy for lyophilized orally disintegrating tablets.
Vanbillemont B; De Beer T
Int J Pharm; 2020 Oct; 588():119717. PubMed ID: 32771503
[TBL] [Abstract][Full Text] [Related]
29. Geriatric-Oriented High Dose Nutraceutical ODTs: Formulation and Physicomechanical Characterization.
Agiba AM; Abdel-Hamid S; Nasr M; Geneidi AS
Curr Drug Deliv; 2018 Feb; 15(2):267-277. PubMed ID: 28322163
[TBL] [Abstract][Full Text] [Related]
30. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
Tawfeek HM; Faisal W; Soliman GM
Pharm Dev Technol; 2018 Jun; 23(5):496-503. PubMed ID: 28489472
[TBL] [Abstract][Full Text] [Related]
31. Design, development, and optimization of orally disintegrating tablets of etoricoxib using vacuum-drying approach.
Patel D; Shah M; Shah S; Shah T; Amin A
PDA J Pharm Sci Technol; 2008; 62(3):224-32. PubMed ID: 18661871
[TBL] [Abstract][Full Text] [Related]
32. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
[TBL] [Abstract][Full Text] [Related]
34. Preparation and evaluation of orally disintegrating tablets containing vitamin E as a model fat-soluble drug.
Ikematsu Y; Uchida S; Namiki N
Chem Pharm Bull (Tokyo); 2015; 63(3):156-63. PubMed ID: 25757486
[TBL] [Abstract][Full Text] [Related]
35. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
36. Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
Tranová T; Loskot J; Navrátil O; Brniak W; Mužíková J
Int J Pharm; 2023 Apr; 636():122838. PubMed ID: 36921743
[TBL] [Abstract][Full Text] [Related]
37. Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets.
Braig V; Konnerth C; Peukert W; Lee G
Int J Pharm; 2019 Jan; 554():54-60. PubMed ID: 30278257
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
39. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
40. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
Assaf SM; Qandil AM; Al-Ani EA
Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
